Shanafelt, T. D., Wang, X. V., Kay, N. E., Hanson, C. A., O’Brien, S., Barrientos, J., . . . Tallman, M. (2019). Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia. N Engl J Med.
Citação norma ChicagoShanafelt, Tait D., et al. "Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia." N Engl J Med 2019.
MLA CitationShanafelt, Tait D., et al. "Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia." N Engl J Med 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.